NOTCH2 mutation
|
NSCLC
|
NOTCH2 mutation
|
NSCLC
|
Immunotherapy Sensitive: C3 – Early Trials
|
Immunotherapy Sensitive: C3 – Early Trials
|
NOTCH2 mutation
|
Diffuse Large B Cell Lymphoma
|
NOTCH2 mutation
|
Diffuse Large B Cell Lymphoma
|
R-CHOP Resistant: C3 – Early Trials
|
R-CHOP Resistant: C3 – Early Trials
|
NOTCH2 mutation
|
Triple Negative Breast Cancer
|
NOTCH2 mutation
|
Triple Negative Breast Cancer
|
PF-03084014 Sensitive: D – Preclinical
|
PF-03084014 Sensitive: D – Preclinical
|